drugset

drugset / Trial / NCT06337981

Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

NCT06337981 ↗

Phase 2 Completed 99 enrolled AJU Pharm Co., Ltd. GL Pharm Tech Corporation · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is planned to Evaluate the Efficacy and Safety of test drug (AJU-S56) compared to control drug(vehicle) in Patients with Dry Eye Disease.

Timeline

Start: 2021-11-22
Primary completion: 2022-06-14
Completion: 2022-11-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AJU-S56	Unknown	5 %	—

Indications